Longer-term (up to 6 years) efficacy of ofatumumab in recently diagnosed treatment-naive relapsing multiple sclerosis

Category Primary study
Conference10th Congress of the European Academy of Neurology
Year 2024
This article has no abstract
Epistemonikos ID: 0a88f1338379df3e45c453029fb0fd36d8178709
First added on: Jan 10, 2026